Stay updated on Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.

Latest updates to the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page
- Check2 days agoChange DetectedThe homepage now shows 602,520 studies, up from 601,694, reflecting an expansion in the registered studies listed on the site.SummaryDifference0.1%

- Check9 days agoChange DetectedThe homepage text was updated to show 601,694 studies across all 50 states and 226 countries and territories, replacing the previous figure of 600,762. This reflects the current size of the ClinicalTrials.gov database.SummaryDifference0.1%

- Check16 days agoChange DetectedClinicalTrials.gov is a place to learn about 600,762 studies with locations in all 50 states and in 226 countries and territories, up from 599,765. The site revision has been updated to v3.6.6 (from v3.6.5).SummaryDifference0.3%

- Check23 days agoChange DetectedThe homepage text updates the total number of studies from 598,690 to 599,765, reflecting a refreshed database size across all 50 states and 226 countries.SummaryDifference0.1%

- Check30 days agoChange DetectedThe homepage stat about the total number of studies has been updated to 598,690, replacing the previous figure of 597,691 to reflect the current dataset size.SummaryDifference0.1%

- Check37 days agoChange DetectedOn the homepage, the total number of studies listed increases from 596,690 to 597,691, reflecting a larger database. The revision/version label also updates from v3.6.4 to v3.6.5.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.